These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22101281)

  • 21. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
    Packhaeuser CB; Kissel T
    J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of sustained release microparticles with improved initial release property.
    Jung GY; Na YE; Park MS; Park CS; Myung PK
    Arch Pharm Res; 2009 Mar; 32(3):359-65. PubMed ID: 19387579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of storage temperature and moisture on the performance of microsphere/hydrogel composites.
    Wang Y; Burgess DJ
    Int J Pharm; 2013 Sep; 454(1):310-5. PubMed ID: 23811131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A biodegradable filament for controlled drug delivery.
    Mack BC; Wright KW; Davis ME
    J Control Release; 2009 Nov; 139(3):205-11. PubMed ID: 19567255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of the release characteristics of estradiol encapsulated in PLGA particles via surface coating.
    Enayati M; Stride E; Edirisinghe M; Bonfield W
    Ther Deliv; 2012 Feb; 3(2):209-26. PubMed ID: 22834198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release.
    Thote AJ; Gupta RB
    Nanomedicine; 2005 Mar; 1(1):85-90. PubMed ID: 17292062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres.
    Xu Q; Crossley A; Czernuszka J
    J Pharm Sci; 2009 Jul; 98(7):2377-89. PubMed ID: 19009589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controllable promotion of chondrocyte adhesion and growth on PVA hydrogels by controlled release of TGF-β1 from porous PLGA microspheres.
    Nie L; Zhang G; Hou R; Xu H; Li Y; Fu J
    Colloids Surf B Biointerfaces; 2015 Jan; 125():51-7. PubMed ID: 25437063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery.
    Feng R; Zhang Z; Li Z; Huang G
    Drug Deliv; 2014 May; 21(3):185-92. PubMed ID: 24107001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin loaded PLGA microspheres: effect of zinc salts on encapsulation, release, and stability.
    Manoharan C; Singh J
    J Pharm Sci; 2009 Feb; 98(2):529-42. PubMed ID: 18548615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro / in vivo evaluation of NCDS-micro-fabricated biodegradable implant.
    Park CW; Rhee YS; Park SH; Danh SD; Ahn SH; Chi SC; Park ES
    Arch Pharm Res; 2010 Mar; 33(3):427-32. PubMed ID: 20361308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of noncytotoxic PLGA nanoparticles to improve the effect of a new inhibitor of p53-MDM2 interaction.
    Paiva AM; Pinto RA; Teixeira M; Barbosa CM; Lima RT; Vasconcelos MH; Sousa E; Pinto M
    Int J Pharm; 2013 Sep; 454(1):394-402. PubMed ID: 23856033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo performance of dexamethasone loaded PLGA microspheres prepared using polymer blends.
    Gu B; Wang Y; Burgess DJ
    Int J Pharm; 2015 Dec; 496(2):534-40. PubMed ID: 26520407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
    Mok H; Park TG
    Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of spray-drying parameters on phase behavior, drug distribution, and in vitro release of injectable microspheres for sustained release.
    Meeus J; Lenaerts M; Scurr DJ; Amssoms K; Davies MC; Roberts CJ; Van Den Mooter G
    J Pharm Sci; 2015 Apr; 104(4):1451-60. PubMed ID: 25648704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels.
    Galeska I; Kim TK; Patil SD; Bhardwaj U; Chatttopadhyay D; Papadimitrakopoulos F; Burgess DJ
    AAPS J; 2005 Sep; 7(1):E231-40. PubMed ID: 16146344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.